For patients pairing B12 with NAD+ IV therapy during energy-focused protocols, B12 typically runs weekly between NAD+ sessions and helps sustain the cellular energy benefits between infusions
As an elective wellness service, MIC Plus B12 is not intended to diagnose or treat any medical condition
Six clinical trials enrolling ~900 participants demonstrated excellent safety but the pivotal Phase IIb trial failed to show clinically meaningful weight loss, leading to development termination in 2007
The problem with most copper peptide serums is the main active ingredient is buried underneath 20+ other compounds
evening dosing has been linked to sleep disruption because of the metabolic activation effect
Instead of overcoming the metabolic adaptation, higher doses frequently exacerbate side effects like nausea, fatigue, and gastrointestinal distress